Compare JUBILANT LIFE SCIENCES with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES FULFORD INDIA JUBILANT LIFE SCIENCES/
FULFORD INDIA
 
P/E (TTM) x 15.2 398.8 3.8% View Chart
P/BV x 1.8 6.2 28.6% View Chart
Dividend Yield % 0.8 0.1 989.5%  

Financials

 JUBILANT LIFE SCIENCES   FULFORD INDIA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-19
FULFORD INDIA
Mar-14
JUBILANT LIFE SCIENCES/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs898942 95.3%   
Low Rs618450 137.2%   
Sales per share (Unadj.) Rs572.0691.4 82.7%  
Earnings per share (Unadj.) Rs36.211.5 316.1%  
Cash flow per share (Unadj.) Rs59.515.4 387.5%  
Dividends per share (Unadj.) Rs4.502.00 225.0%  
Dividend yield (eoy) %0.60.3 206.7%  
Book value per share (Unadj.) Rs301.9380.0 79.5%  
Shares outstanding (eoy) m159.283.90 4,084.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.31.0 131.6%   
Avg P/E ratio x20.960.7 34.4%  
P/CF ratio (eoy) x12.745.3 28.1%  
Price / Book Value ratio x2.51.8 137.0%  
Dividend payout %12.417.4 71.2%   
Avg Mkt Cap Rs m120,6942,714 4,446.4%   
No. of employees `0002.40.4 538.3%   
Total wages/salary Rs m19,260505 3,813.8%   
Avg. sales/employee Rs Th38,120.66,073.0 627.7%   
Avg. wages/employee Rs Th8,058.41,137.4 708.5%   
Avg. net profit/employee Rs Th2,414.3100.7 2,398.1%   
INCOME DATA
Net Sales Rs m91,1082,696 3,378.9%  
Other income Rs m357125 285.0%   
Total revenues Rs m91,4662,822 3,241.4%   
Gross profit Rs m17,390-46 -37,478.7%  
Depreciation Rs m3,70915 24,401.3%   
Interest Rs m2,19810 23,137.9%   
Profit before tax Rs m11,84054 21,805.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,8020-   
Tax Rs m3,26810 34,041.7%   
Profit after tax Rs m5,77045 12,908.5%  
Gross profit margin %19.1-1.7 -1,109.2%  
Effective tax rate %27.617.7 156.1%   
Net profit margin %6.31.7 382.0%  
BALANCE SHEET DATA
Current assets Rs m45,8481,738 2,637.5%   
Current liabilities Rs m20,897545 3,836.5%   
Net working cap to sales %27.444.3 61.9%  
Current ratio x2.23.2 68.7%  
Inventory Days Days5748 117.2%  
Debtors Days Days514 1,183.4%  
Net fixed assets Rs m65,49812 550,403.7%   
Share capital Rs m15939 408.5%   
"Free" reserves Rs m47,9301,443 3,321.5%   
Net worth Rs m48,0891,482 3,244.9%   
Long term debt Rs m42,4290-   
Total assets Rs m114,6852,077 5,522.5%  
Interest coverage x6.46.7 95.1%   
Debt to equity ratio x0.90-  
Sales to assets ratio x0.81.3 61.2%   
Return on assets %6.92.6 266.2%  
Return on equity %12.03.0 397.8%  
Return on capital %12.44.3 288.3%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m12,42217 72,220.9%   
Fx outflow Rs m17,227673 2,559.1%   
Net fx Rs m-4,805-656 732.5%   
CASH FLOW
From Operations Rs m11,21590 12,461.2%  
From Investments Rs m-10,118105 -9,673.4%  
From Financial Activity Rs m6,574-14 -46,626.2%  
Net Cashflow Rs m7,612181 4,217.3%  

Share Holding

Indian Promoters % 45.6 0.0 -  
Foreign collaborators % 3.5 75.0 4.7%  
Indian inst/Mut Fund % 8.7 3.8 228.9%  
FIIs % 21.2 0.1 21,200.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 21.2 99.5%  
Shareholders   23,815 4,783 497.9%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  DR. REDDYS LAB  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY19); Net Profit Up 25.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 25.7% YoY). Sales on the other hand came in at Rs 24 bn (up 15.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Sep 16, 2019 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS